Literature DB >> 18607725

Principles and analysis of hematopoietic stem cell transplantation outcomes: the physician's perspective.

Mary Eapen1, Vanderson Rocha.   

Abstract

Hematopoietic stem cell transplantation (HSCT) is used widely for the treatment of malignant and non-malignant diseases. Advances in transplantation strategies such as modifications to existing transplant-conditioning regimens to lower morbidity and mortality, use of alternative donors and grafts, supportive care including graft-versus-host disease prophylaxis and antimicrobial therapy have led to increasing numbers of HSCT being performed. The procedure is now available to children, young and older adults with an ever increasing number of survivors from this procedure. Analysis of outcomes after HSCT giving consideration to existing strategies warrants using appropriate statistical methodology. This is critical not only in documenting the current success of HSCT but to plan future strategies to optimize accessibility to HSCT, donor and graft choices, patient selection, counsel potential HSCT candidates and long-term survivors and plan intervention trials for these persons. We describe concepts and principles of HSCT to better understand the complexities associated with outcome analysis.

Entities:  

Mesh:

Year:  2008        PMID: 18607725     DOI: 10.1007/s10985-008-9090-4

Source DB:  PubMed          Journal:  Lifetime Data Anal        ISSN: 1380-7870            Impact factor:   1.588


  20 in total

1.  Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome.

Authors:  F H Bach; R J Albertini; P Joo; J L Anderson; M M Bortin
Journal:  Lancet       Date:  1968-12-28       Impact factor: 79.321

2.  Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes.

Authors:  Giorgio La Nasa; Claudio Giardini; Francesca Argiolu; Franco Locatelli; Marcella Arras; Piero De Stefano; Antonio Ledda; Antonella Pizzati; Maria A Sanna; Adriana Vacca; Guido Lucarelli; Licinio Contu
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

Review 3.  Current status of hematopoietic stem cell transplantation after nonmyeloablative conditioning.

Authors:  Frédéric Baron; Brenda M Sandmaier
Journal:  Curr Opin Hematol       Date:  2005-11       Impact factor: 3.284

4.  Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.

Authors:  Vanderson Rocha; Myriam Labopin; Guillermo Sanz; William Arcese; Rainer Schwerdtfeger; Alberto Bosi; Niels Jacobsen; Tapani Ruutu; Marcos de Lima; Jürgen Finke; Francesco Frassoni; Eliane Gluckman
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

5.  Solid cancers after bone marrow transplantation.

Authors:  R E Curtis; P A Rowlings; H J Deeg; D A Shriner; G Socíe; L B Travis; M M Horowitz; R P Witherspoon; R N Hoover; K A Sobocinski; J F Fraumeni; J D Boice
Journal:  N Engl J Med       Date:  1997-03-27       Impact factor: 91.245

6.  Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-center comparative analysis of genoidentical, haploidentical or unrelated donors.

Authors:  S Caillat-Zucman; F Le Deist; E Haddad; M Gannagé; L Dal Cortivo; N Jabado; S Hacein-Bey-Abina; S Blanche; J-L Casanova; A Fischer; M Cavazzana-Calvo
Journal:  Bone Marrow Transplant       Date:  2004-06       Impact factor: 5.483

7.  Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia.

Authors:  Norbert Schmitz; Meral Beksac; Dirk Hasenclever; Andrea Bacigalupo; Tapani Ruutu; Arnon Nagler; Eliane Gluckman; Nigel Russell; Jane F Apperley; Norbert C Gorin; Jeff Szer; Ken Bradstock; Agnes Buzyn; Peter Clark; Keith Borkett; Alois Gratwohl
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

8.  Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

Authors:  Stephanie J Lee; John P Klein; A John Barrett; Olle Ringden; Joseph H Antin; Jean-Yves Cahn; Matthew H Carabasi; Robert Peter Gale; Sergio Giralt; Gregory A Hale; Osman Ilhan; Philip L McCarthy; Gerard Socie; Leo F Verdonck; Daniel J Weisdorf; Mary M Horowitz
Journal:  Blood       Date:  2002-07-15       Impact factor: 22.113

9.  Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study.

Authors:  Mary Eapen; Pablo Rubinstein; Mei-Jie Zhang; Cladd Stevens; Joanne Kurtzberg; Andromachi Scaradavou; Fausto R Loberiza; Richard E Champlin; John P Klein; Mary M Horowitz; John E Wagner
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

10.  Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.

Authors:  Eliane Gluckman; Vanderson Rocha; Irina Ionescu; Marc Bierings; Richard E Harris; John Wagner; Joanne Kurtzberg; Martin A Champagne; Carmem Bonfim; Marco Bittencourt; Philip Darbyshire; Manuél-Nicolas Fernandez; Franco Locatelli; Ricardo Pasquini
Journal:  Biol Blood Marrow Transplant       Date:  2007-07-20       Impact factor: 5.742

View more
  1 in total

1.  Bone marrow rejuvenation. An excellent potential therapy for age-related endothelial dysfunction.

Authors:  Min Gong; Bin Yu; Yi-Gang Wang; Meifeng Xu
Journal:  Circ J       Date:  2013-10-16       Impact factor: 2.993

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.